Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Howland, Robert H.
2012.
The Challenges of Clinical Psychopharmacological Management.
Journal of Psychosocial Nursing and Mental Health Services,
Vol. 50,
Issue. 5,
p.
17.
Akhavan, Pooneh S.
Su, Jiandong
Lou, Wendy
Gladman, Dafna D.
Urowitz, Murray B.
and
Fortin, Paul R.
2013.
The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus.
The Journal of Rheumatology,
Vol. 40,
Issue. 6,
p.
831.
Simooya, Oscar Ozmund
2014.
A worldwide yearly survey of new data in adverse drug reactions and interactions.
Vol. 35,
Issue. ,
p.
495.
Das, Piyush
Rai, Abhishek
Chopra, Amit
and
Philbrick, Kemuel
2014.
Psychosis Likely Induced by Hydroxychloroquine in a Patient With Chronic Q Fever: A Case Report and Clinically Relevant Review of Pharmacology.
Psychosomatics,
Vol. 55,
Issue. 4,
p.
409.
Manzo, Ciro
Gareri, Pietro
and
Castagna, Alberto
2017.
Psychomotor Agitation Following Treatment with Hydroxychloroquine.
Drug Safety - Case Reports,
Vol. 4,
Issue. 1,
Mascolo, Annamaria
Berrino, Pasquale Maria
Gareri, Pietro
Castagna, Alberto
Capuano, Annalisa
Manzo, Ciro
and
Berrino, Liberato
2018.
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article.
Inflammopharmacology,
Vol. 26,
Issue. 5,
p.
1141.
Hamm, Brandon S.
and
Rosenthal, Lisa J.
2020.
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
Psychosomatics,
Vol. 61,
Issue. 6,
p.
597.
Rani, Seema
Grover, Sandeep
Mehra, Aseem
and
Sahoo, Swapnajeet
2020.
Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients.
Indian Journal of Pharmacology,
Vol. 52,
Issue. 3,
p.
229.
Lane, Jennifer C E
Weaver, James
Kostka, Kristin
Duarte-Salles, Talita
Abrahao, Maria Tereza F
Alghoul, Heba
Alser, Osaid
Alshammari, Thamir M
Areia, Carlos
Biedermann, Patricia
Banda, Juan M
Burn, Edward
Casajust, Paula
Fister, Kristina
Hardin, Jill
Hester, Laura
Hripcsak, George
Kaas-Hansen, Benjamin Skov
Khosla, Sajan
Kolovos, Spyros
Lynch, Kristine E
Makadia, Rupa
Mehta, Paras P
Morales, Daniel R
Morgan-Stewart, Henry
Mosseveld, Mees
Newby, Danielle
Nyberg, Fredrik
Ostropolets, Anna
Woong Park, Rae
Prats-Uribe, Albert
Rao, Gowtham A
Reich, Christian
Rijnbeek, Peter
Sena, Anthony G
Shoaibi, Azza
Spotnitz, Matthew
Subbian, Vignesh
Suchard, Marc A
Vizcaya, David
Wen, Haini
Wilde, Marcel de
Xie, Junqing
You, Seng Chan
Zhang, Lin
Lovestone, Simon
Ryan, Patrick
and
Prieto-Alhambra, Daniel
2021.
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Rheumatology,
Vol. 60,
Issue. 7,
p.
3222.
Davis, Joshua
Umeh, Ugochukwu
and
Saba, Rand
2021.
Treatment of SARS-CoV-2 (COVID-19): A safety perspective.
World Journal of Pharmacology,
Vol. 10,
Issue. 1,
p.
1.
Pasyk, Stanislav
Maharaj, Shyam
and
Bourgeois, James A.
2022.
Psychonephrology.
p.
241.
Askarian, Fatemeh
Firoozi, Zahra
Ebadollahi-Natanzi, Alireza
Bahrami, Solmaz
and
Rahimi, Hamid-Reza
2022.
A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients.
Toxicological Research,
Vol. 38,
Issue. 2,
p.
137.
MANDACI, Melike
SARANDÖL, Aslı
and
AKKAYA, Cengiz
2022.
Bipolar Bozukluk ve Romatoid Artrit İlişkisi.
Psikiyatride Güncel Yaklaşımlar,
Vol. 14,
Issue. 2,
p.
131.
Talarico, Fernanda
Chakravarty, Sucheta
Liu, Yang S.
Greenshaw, Andrew J.
Passos, Ives Cavalcante
and
Cao, Bo
2023.
Systematic Review of Psychiatric Adverse Effects Induced by Chloroquine and Hydroxychloroquine: Case Reports and Population Studies.
Annals of Pharmacotherapy,
Vol. 57,
Issue. 4,
p.
463.